Premier Path Wealth Partners’s HCA Healthcare HCA Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$1.2M Buy
2,810
+360
+15% +$148K 0.14% 134
2026
Q2
$955K Buy
2,450
+148
+6% +$62.6K 0.11% 175
2026
Q1
$1.09M Buy
2,302
+348
+18% +$175K 0.14% 147
2025
Q4
$912K Buy
1,954
+163
+9% +$75.7K 0.12% 169
2025
Q3
$763K Buy
1,791
+9
+0.5% +$3.49K 0.1% 207
2025
Q2
$683K Buy
1,782
+340
+24% +$123K 0.1% 214
2025
Q1
$498K Buy
1,442
+74
+5% +$23.8K 0.08% 229
2024
Q4
$411K Sell
1,368
-19
-1% -$6.64K 0.06% 254
2024
Q3
$564K Sell
1,387
-6
-0.4% -$2.2K 0.09% 219
2024
Q2
$448K Buy
1,393
+36
+3% +$11.7K 0.08% 236
2024
Q1
$453K Buy
1,357
+49
+4% +$15K 0.09% 222
2023
Q4
$354K Buy
+1,308
New +$323K 0.08% 231

Other funds holding HCA

Premier Path Wealth Partners's HCA Position: Q3 2026 in Review

Premier Path Wealth Partners increased its HCA Healthcare (HCA) stake by 15% in Q3 2026, buying an estimated $148K and bringing the position to 2,810 shares worth $1.2M. The position accounts for 0.14% of the portfolio, ranked #134.

Premier Path Wealth Partners first reported a position in HCA in Q4 2023 and has held it in 12 quarters since. 713 funds tracked by Wall St. Rank hold HCA as of Q3 2026.

  • Premier Path Wealth Partners held 2,810 shares of HCA Healthcare worth $1.2M as of Q3 2026.
  • Premier Path Wealth Partners bought 360 HCA Healthcare shares in Q3 2026, an estimated $148K.
  • HCA Healthcare made up 0.14% of Premier Path Wealth Partners's portfolio in Q3 2026, its #134 holding.
  • Premier Path Wealth Partners first reported a position in HCA Healthcare in Q4 2023 and has held it in 12 quarters since.
  • 713 funds tracked by Wall St. Rank held HCA Healthcare as of Q3 2026.

Based on Premier Path Wealth Partners's 13F filing for Q3 2026, filed 16 Oct 2026.